# SUNOSI

NDC: 81968-351
Generic name: solriamfetol
Labeler / Manufacturer: Axsome Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190618

FDA application: NDA211230

## Active ingredients

- SOLRIAMFETOL: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81968-351"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81968-351
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=362f206b-73e7-4009-8c34-5a9df55679ab